BBVA
ALDX icon

Banco Bilbao Vizcaya Argentaria’s Aldeyra Therapeutics ALDX Stock Holding History

Banco Bilbao Vizcaya Argentaria’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-313,889
Closed -$1.31M – 678
2020
Q2 		$1.31M Buy
313,889
+263,889
+528% +$964K 0.04% 331
2020
Q1 		$123K Buy
50,000
+30,000
+150% +$135K ﹤0.01% 646
2019
Q4 		$116K Buy
+20,000
New +$116K ﹤0.01% 700

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Banco Bilbao Vizcaya Argentaria's ALDX Position: Q3 2020 in Review

Banco Bilbao Vizcaya Argentaria sold out of Aldeyra Therapeutics (ALDX) in Q3 2020, closing a stake of 313,889 shares — an estimated $1.31M sold.

Banco Bilbao Vizcaya Argentaria first reported a position in ALDX in Q4 2019 and held it in 3 quarters. The position peaked at $1.31M in Q2 2020. 87 funds tracked by Wall St. Rank hold ALDX as of Q3 2020.

  • Banco Bilbao Vizcaya Argentaria reported no remaining Aldeyra Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Banco Bilbao Vizcaya Argentaria sold 313,889 Aldeyra Therapeutics shares in Q3 2020, an estimated $1.31M.
  • Banco Bilbao Vizcaya Argentaria first reported a position in Aldeyra Therapeutics in Q4 2019 and held it in 3 quarters.
  • Banco Bilbao Vizcaya Argentaria's Aldeyra Therapeutics position peaked at $1.31M in Q2 2020.
  • 87 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q3 2020.

Based on Banco Bilbao Vizcaya Argentaria's 13F filing for Q3 2020, filed 12 Nov 2020.